Drug Name: | Teicoplanin |
---|
Drug Class: | Glycopeptide Antibiotic |
---|
Mechanism of Action: | - Inhibits bacterial cell wall synthesis by binding to D-alanyl-D-alanine residues
- Prevents cross-linking of peptidoglycan chains, leading to bacterial cell death
|
---|
Use: | - Treatment of serious gram-positive bacterial infections
- Methicillin-resistant Staphylococcus aureus (MRSA) infections
- Endocarditis
- Septicemia
- Bone and joint infections
- Skin and soft tissue infections
|
---|
Side Effects: | - Nausea
- Vomiting
- Diarrhea
- Rash
- Hypersensitivity reactions
- Renal toxicity
- Hepatic toxicity
- Thrombocytopenia
|
---|
Contraindications: | - Hypersensitivity to teicoplanin or other glycopeptide antibiotics
- Severe renal impairment
- Pregnancy and lactation
|
---|
Specialty: | - Infectious Disease
- Critical Care
- Internal Medicine
|
---|